May 2, 2024 Journal article Open Access

Mollalign Aligaz Adisu

DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://nadre.ethernet.edu.et/record/16688">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://nadre.ethernet.edu.et/record/16688</dct:identifier>
    <foaf:page rdf:resource="https://nadre.ethernet.edu.et/record/16688"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Mollalign Aligaz Adisu</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Woldiya University</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Second dose of measles-containing vaccine coverage and associated factors among children aged 24 36 months in Gondar city, Central Gondar, Northwest Ethiopia, 2023</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2024</dct:issued>
    <dcat:keyword>second dose, measles, vaccination, coverage, Gondar, Ethiopia</dcat:keyword>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Worknesh Akanaw Bogale and Tewodros Getaneh Alemu</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>University of Gondar</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2024-05-02</dct:issued>
    <owl:sameAs rdf:resource="https://nadre.ethernet.edu.et/record/16688"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://nadre.ethernet.edu.et/record/16688</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <owl:sameAs rdf:resource="https://doi.org/10.3389/fpubh.2024.1364865"/>
    <dct:description>&lt;p&gt;Background: Measles caused 207,000 deaths worldwide in 2019. Ethiopia ranks among the top&amp;nbsp;10 countries in the world with the highest number of measles cases. However, the coverage of the second dose of measles-containing vaccine (MCV2) remains low. To increase coverage, the government of Ethiopia launched a nationwide measles vaccination campaign. Despite this intervention, the coverage is still below target, and there is scarce information in the study area. Therefore, this study aimed to assess MCV2 coverage and associated factors among children aged 24&amp;ndash;36&amp;thinsp;months in Gondar city, Central Gondar, Northwest Ethiopia, 2023. Methods: A community-based cross-sectional study was conducted among 621 children aged 24&amp;ndash;36&amp;thinsp;months using a systematic random sampling technique from 25 April to 25 May. A pre-tested, interviewer-administered, and structured questionnaire was used and collected using Kobo Toolbox and then transferred to Stata version 17 for further analysis. The binary logistic regression model was used to identify factors, and the presence of an association was declared using a p-value of &amp;lt;0.05. Similarly, an adjusted odds ratio with a 95% confidence interval was used to interpret the direction and strength of an association. Results: A total of 621 children, with a response rate of 98.1%, participated in the study. The coverage of the second dose of MCV was 75.68% (95% CI: 72.1&amp;ndash;78.9). The following factors were significantly associated with measles-containing vaccine second dose (MCV2) coverage: father as the household head (AOR: 3.06, 95% CI: 1.43&amp;ndash;6.44), first birth order (AOR: 4.45, 95% CI: 1.21&amp;ndash;16.3), four and above antenatal care (ANC) follow-ups (AOR: 5.18, 95% CI:1.62&amp;ndash;16.5), postnatal care (PNC) service utilization (AOR: 2.57, 95% CI:1.27&amp;ndash;5.15), at least two doses of vitamin A uptake (AOR: 6.39, 95% CI: 2.67&amp;ndash;15.2), mothers having high awareness (AOR: 1.97, 95% CI:1.15&amp;ndash;3.4), and good perception (AOR: 3.6, 95% CI: 2&amp;ndash;6.47) about measles vaccination. Conclusion and recommendations: The coverage of MCV2&amp;nbsp;in the study area is lower than the national and global target of above 95%. Head of household, birth order, ANC follow-up, PNC service utilization, vitamin A uptake, awareness, and perception of mothers about measles vaccination were significant factors for MCV2 coverage. Creating awareness, increasing the perception of mothers&amp;nbsp;about measles vaccination, and strengthening the ANC and PNC services will increase the coverage.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dct:license rdf:resource="https://creativecommons.org/licenses/by-nc/4.0/"/>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.3389/fpubh.2024.1364865"/>
        <dcat:byteSize>580346</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://nadre.ethernet.edu.et/record/16688/files/Second dose of.pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>